SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John T. Hardee who wrote (927)10/14/1997 12:37:00 AM
From: Amigo Mike   of 1172
 
CMTR will move higher. Consider this. Astra Merck paid $2.4 million to CMTR two weeks ago. That's .50 per share plus CMTR can sign with other companies now to market the H Pylori test kit. There are approx 8 million test done yearly in the US for H pylori. The test is an endoscopy(sp) which is invasive and costly. CMTR test kit is non invasive and can be done during a doctor visit with near immediate results.

Then CMTR inks a deal with CVS for the home drug test kit. This kit was likely the subject of the 20/20 story last week. Parental empowerment in the war on drugs could make this kit a very big deal. My guess is that these two deals are worth about $1.50 alone to the share price.

Looking for CMTR to pick up another distribution channel .... for both drug test kit and h pylori kit shortly.
Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext